According to Eiring and collaborators, the downregulation of miR-328 by BCR-ABL1 is observed in CML-BP cells but not in CML-CP cells and supports CML progression to BP through differentiation arrest [176]. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.